ok Folks...there has been some pretty strong words tossed around in regards to silversol....I'm posting articles about the Food and Drug Administration
approving of American Biotech Lab to market Silversol gel for wound dressing...and then then an article on it's uses in various places....plus it's initial testing on several forms of the bird flu...These article were written in 2007. It's now 2013. I tried to mark specific lines in bold...you will have to scroll down some of the articles...and these articles were taken from medical magazines etc
Also the Environmental Protection Agency
has given approval for the use in disinfecting. (All you folks who think Silversol is bad, BEWARE...your dentist might be using it in their dental lines....)
If you read these articles...you will see this product is not made at home by kooky weirdos trying to self medicate...patents have been approved, studies conducted by numerous schools...plus the approval of two well known governmental agencies...
In one of the articles you will find "no known side affects" no one has ever turned blue because it's made differently than Colloidal Silver.
I can't change a persons mind...I can present articles that show its a viable product that DOCTORS are recommending....I have talked to several that use it themselves...one little sidenote I live in an area where we have access to with renowned hospitals (Pittsburgh) In one of the hospitals I was visiting, they actually have special classes and centers to treat patients holistically....including herbal medicine, meditation, etc....this is the new and upcoming medical treatment.
Source: American Biotech L
The FDA approval letter confirms that ABL may market ASAP Wound Dressing Gel "for the topical management of minor cuts, lacerations, abrasions, 1st and 2nd degree burns, and skin irritations." The product utilizes ABL's innovative SilverSol
The FDA approval letter confirms that ABL may market ASAP Wound Dressing Gel "for the topical management of minor cuts, lacerations, abrasions, 1st and 2nd degree burns, and skin irritations." The product utilizes ABL's innovative SilverSol Technology, which has garnered multiple patents in the U.S. and several countries throughout the world, including a broad-use patent that provides the company with exclusive rights to use its silver-based products to combat many of the world's most destructive pathogens, including malaria, tuberculosis, MRSA and HIV.
"We are delighted with the FDA's decision to grant approval for ABL to broadly market our ASAP Wound Dressing Gel," said Dr. William Moeller, a managing director of American Biotech Labs. "We feel this is a singularly effective wound care product, and it is a tremendous validation for us that ABL products have now received approval from the FDA as well as from the EPA."
ABL has performed extensive anti-microbial studies against bacteria, yeast, fungus and other pathogens. Information about these studies is available at research section of the ABL Website, www.americanbiotechlabs.com/researchprotected/researchmenu.html
About American Biotech Labs
American Biotech Labs (ABL; www.americanbiotechlabs.comABL's silver hydrosol has consistently demonstrated the ability, without any known toxic side effects, to destroy a wide range of bacteria, viruses, yeast, and moldsBird Flu - American Biotech Labs Announces Results of Preliminary Tests for Multiple Avian Bird Flu Strains Using Patented ABL SilverSol Technology(TM)
Cancer - NIST Awards $2 Million to 20/20 GeneSystems for Innovative Tumor Profiling Technology
Clinical Trial Research - Noven Announces Results of Phase 3 Clinical Study of Once-Daily Lithium Product
Drug Delivery - Nastech Pharmaceutical Company Announces the Jeffrey Wenig Memorial Award for Outstanding Achievement in Drug Delivery
Vaccines - Prof. Michel Klein Becomes Chief Scientific Officer at AMVACBird Flu
American Biotech Labs Announces Results of Preliminary Tests for Multiple Avian Bird Flu Strains Using Patented ABL SilverSol Technology(TM)
Published in Medical Patent Law Weekly, October 24th, 2007
American Biotech Labs (ABL; www.AmericanBiotechLabs.com), creator of a line of powerful products that utilize patented ABL SilverSol Technology(TM) to combat pathogens associated with many of the world's most harmful diseases, announced successful preliminary results on tests performed using the company's products against two strains of the avian bird flu virus.
Preliminary in vitro animal study tests performed by two separate independent laboratories, using the company's ABL SilverSol Technology at 10 parts per million against two strains of the H5-N1 subtype of the Avian Bird Flu virus, indicated that the ABL products were able to neutralize the virus.
Want to see the full article?
?Purchase this article for only $3.00